TAMMY WILLIAMS: Open Payments
NPI 1285877258 · STARKE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 46 payments from 17 companies in 2025. Trend: 2023 $698 · 2024 $497 · 2025 $1,206
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $343 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $229 |
| ABBVIE INC. | 6 | $133 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| Astellas Pharma US Inc | 3 | $70 |
| Amgen Inc. | 2 | $47 |
| PFIZER INC. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| IBSA Pharma Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
Products named: Kerendia, Biktarvy, Epclusa, VRAYLAR, TRELEGY ELLIPTA, Veozah, OTEZLA, QULIPTA.
Industry payments across FL — which companies pay providers there.
